NCT04923152View on ClinicalTrials.gov

Effective Dose of Statin Post PCI

NACompletedINTERVENTIONAL
Enrollment

582

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 1, 2021

Study Completion Date

April 1, 2021

Conditions
Statin Dose
Interventions
DRUG

moderate statin dose

5 mg rosuvastatin per day

DRUG

high dose statin

40 mg rosuvastatin per day

Trial Locations (1)

55318

Professor kojuri cardiology clinic, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT04923152 - Effective Dose of Statin Post PCI | Biotech Hunter | Biotech Hunter